SS
COCP icon

Sunbelt Securities’s Cocrystal Pharma COCP Stock Holding History

Sunbelt Securities’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,000
Closed -$6K – 418
2019
Q4 		$6K Hold
1,000
– – ﹤0.01% 618
2019
Q3 		$25K Buy
+1,000
New +$25.9K ﹤0.01% 582

Other funds holding COCP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Sunbelt Securities's COCP Position: Q1 2020 in Review

Sunbelt Securities sold out of Cocrystal Pharma (COCP) in Q1 2020, closing a stake of 1,000 shares — an estimated $6K sold.

Sunbelt Securities first reported a position in COCP in Q3 2019 and held it in 2 quarters. The position peaked at $25K in Q3 2019. 24 funds tracked by Wall St. Rank hold COCP as of Q1 2020.

  • Sunbelt Securities reported no remaining Cocrystal Pharma position as of Q1 2020 after selling out during the quarter.
  • Sunbelt Securities sold 1,000 Cocrystal Pharma shares in Q1 2020, an estimated $6K.
  • Sunbelt Securities first reported a position in Cocrystal Pharma in Q3 2019 and held it in 2 quarters.
  • Sunbelt Securities's Cocrystal Pharma position peaked at $25K in Q3 2019.
  • 24 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2020.

Based on Sunbelt Securities's 13F filing for Q1 2020, filed 15 May 2020.